Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

1
RNR MARKET RESEARCH PRESENTS
Prevention and Treatment of Prostate Cancer
Technologies and Global Markets
http//www.rnrmarketresearch.com/prevention-treat
ment-prostate-cancer-technologies-global-markets-m
arket-report.html

• This report provide
• An overview of the market for the prevention and
  treatment of prostate cancer, with coverage of
  the mechanisms of disease development, detection
  and diagnosis, and anticancer agents
• Analyses of global market trends, with data from
  2010, 2011 and 2012, and projections of compound
  annual growth rates (CAGRs) through 2017

2

• Discussion of risk factors, natural history,
  epidemiology, and the genetics of prostate cancer
  
• Examinations of prostate-specific antigen (PSA)
  screening, including the causes of PSA changes,
• PSA thresholds, and controversies over the
  screening
• Coverage of emerging therapies, including
  combination therapy, therapeutic vaccines,
  inhibitors of kinase signaling pathways,
  proteasome inhibitors, angiogenesis inhibitors,
  and immunotherapeutic agents
• Evaluation of prostate cancer treatment products
  by geography, race, and category Breakdown of the
  industry structure, including market shares,
  trends in price and price performance, and
  factors influencing demand
• Comprehensive company profiles.
• Request your sample copy for this report _at_
  http//www.rnrmarketresearch.com/contacts/request-
  sample?rname66083

3
REASONS FOR DOING THIS STUDY This study was
conducted to provide detailed information
regarding screening, testing and treatment
options for prostate cancer. There is an
increasing need for new and innovative
technologies. This industry is experiencing
growth. The use of new drug delivery technologies
for prostate cancer has increased in the past few
years. This study looks at most types of
treatment strategies for the clinical management
of prostate cancer. This BCC market research
report will increase the awareness of current and
emerging drugs and technologies for prostate
cancer, including hormone therapy, chemotherapy,
radiation therapy, surgical therapy,
immunotherapy and also nutrition therapy. SCOPE
OF THE STUDY The scope of this study is testing,
screening technology and also therapeutics
markets for prostate cancer. The report also
includes the regulatory environment, current
technologies, new technologies, prostate cancer
incidence, market projections and market share,
along with latest trends and new
developments. Purchase your copy of this report
_at_ http//www.rnrmarketresearch.com/contacts/purcha
se?rname 66083 For More Details Contact
sales_at_rnrmarketresearch.com